Cargando…

Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer

SIMPLE SUMMARY: A major barrier to success for chimeric antigen receptor (CAR) T-cell therapies in solid tumors is selecting optimal target antigens. Target antigens should be uniformly expressed by cancer cells and minimally so by healthy tissues in the body. Analyzing single-cell RNA-sequencing da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madan, Sanna, Sinha, Sanju, Chang, Tiangen, Gutkind, J. Silvio, Cohen, Ezra E. W., Schäffer, Alejandro A., Ruppin, Eytan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571718/ https://www.ncbi.nlm.nih.gov/pubmed/37835579 http://dx.doi.org/10.3390/cancers15194885

Ejemplares similares

Big data in basic and translational cancer research
por: Jiang, Peng, et al.
Publicado: (2022)

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
por: Sinha, Sanju, et al.
Publicado: (2020)

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)

The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective
por: Ahmadi, Saba, et al.
Publicado: (2022)

mTOR co-targeting strategies for head and neck cancer therapy
por: Wang, Zhiyong, et al.
Publicado: (2017)

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
por: Saddawi-Konefka, Robert, et al.
Publicado: (2021)

Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
por: Israel, Ariel, et al.
Publicado: (2021)

Identification of drugs associated with reduced severity of COVID-19 – a case-control study in a large population
por: Israel, Ariel, et al.
Publicado: (2021)

Head and neck cancers: Safely preserving the talk
por: Munshi, Anusheel
Publicado: (2014)

Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
por: Zhou, Jade Z., et al.
Publicado: (2021)

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
por: Faraji, Farhoud, et al.
Publicado: (2022)

The Promise of Circulating Tumor DNA in Head and Neck Cancer
por: Aulakh, Sukhkaran S., et al.
Publicado: (2022)

Somatic 9p24.1 alterations in HPV(–) head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity
por: Zhao, Xin, et al.
Publicado: (2022)

Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues
por: Crawford, David R., et al.
Publicado: (2022)

Moving ahead on harnessing synthetic lethality to fight cancer
por: Jerby-Arnon, Livnat, et al.
Publicado: (2015)

A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients
por: Zingone, Adriana, et al.
Publicado: (2021)

Exercise as a promising intervention in head & neck cancer patients
por: McNeely, M.L.
Publicado: (2013)

The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies
por: Martin, Daniel, et al.
Publicado: (2014)

A Genome-Wide Systematic Analysis Reveals Different and Predictive Proliferation Expression Signatures of Cancerous vs. Non-Cancerous Cells
por: Waldman, Yedael Y., et al.
Publicado: (2013)

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
por: Wang, Zhiyong, et al.
Publicado: (2021)

Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations
por: Chang, Tian-Gen, et al.
Publicado: (2023)

The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective
por: Marcu, Loredana G., et al.
Publicado: (2018)

Increased MicroRNA Activity in Human Cancers
por: Israel, Ariel, et al.
Publicado: (2009)

Modeling cancer metabolism on a genome scale
por: Yizhak, Keren, et al.
Publicado: (2015)

A pan-cancer study of selenoprotein genes as promising targets for cancer therapy
por: Wu, Wentao, et al.
Publicado: (2021)

Predicting cancer prognosis and drug response from the tumor microbiome
por: Hermida, Leandro C., et al.
Publicado: (2022)

mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations
por: Wang, Zhiyong, et al.
Publicado: (2014)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Aparicio, Cristina, et al.
Publicado: (2021)

Data-Driven Metabolic Pathway Compositions Enhance Cancer Survival Prediction
por: Auslander, Noam, et al.
Publicado: (2016)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Intraoperative Radiation Therapy: A Promising Treatment Modality in Head and Neck Cancer
por: Hilal, Lara, et al.
Publicado: (2017)

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
por: Thomaidou, Arsinoe C., et al.
Publicado: (2022)

Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine
por: Ando, Toshinori, et al.
Publicado: (2022)

Metabolic modeling predicts perturbations extending lifespan in yeast and counteracting aging in mammalian muscle
por: Yizhak, Keren, et al.
Publicado: (2012)

Essential Genes Embody Increased Mutational Robustness to Compensate for the Lack of Backup Genetic Redundancy
por: Cohen, Osher, et al.
Publicado: (2016)

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
por: Cheng, Kuoyuan, et al.
Publicado: (2021)

Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets
por: Cheng, Kuoyuan, et al.
Publicado: (2021)

CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2018)

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2019)

Altered gene expression in excitatory neurons is associated with Alzheimer's disease and its higher incidence in women
por: Garcia, A. Xavier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pgq0md8djh83hlc7ioprb0770u